nodes	percent_of_prediction	percent_of_DWPC	metapath
Dolutegravir—UGT1A1—Ezetimibe—atherosclerosis	0.302	0.352	CbGbCtD
Dolutegravir—UGT1A1—Simvastatin—atherosclerosis	0.281	0.328	CbGbCtD
Dolutegravir—UGT1A1—Lovastatin—atherosclerosis	0.275	0.321	CbGbCtD
Dolutegravir—Musculoskeletal disorder—Rosuvastatin—atherosclerosis	0.00818	0.0719	CcSEcCtD
Dolutegravir—Musculoskeletal disorder—Simvastatin—atherosclerosis	0.00648	0.057	CcSEcCtD
Dolutegravir—UGT1A1—Irinotecan Pathway—NPC1—atherosclerosis	0.00624	0.222	CbGpPWpGaD
Dolutegravir—Myositis—Rosuvastatin—atherosclerosis	0.00596	0.0524	CcSEcCtD
Dolutegravir—Inflammation—Ezetimibe—atherosclerosis	0.0025	0.022	CcSEcCtD
Dolutegravir—Inflammation—Simvastatin—atherosclerosis	0.00239	0.021	CcSEcCtD
Dolutegravir—UGT1A1—Heme degradation—HMOX1—atherosclerosis	0.00205	0.0731	CbGpPWpGaD
Dolutegravir—POU2F2—Ectoderm Differentiation—TNFRSF11B—atherosclerosis	0.00194	0.0692	CbGpPWpGaD
Dolutegravir—Rash maculo-papular—Niacin—atherosclerosis	0.00193	0.017	CcSEcCtD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—HSPD1—atherosclerosis	0.00186	0.0662	CbGpPWpGaD
Dolutegravir—Alanine aminotransferase increased—Ezetimibe—atherosclerosis	0.00155	0.0137	CcSEcCtD
Dolutegravir—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.00155	0.0136	CcSEcCtD
Dolutegravir—Abdominal discomfort—Lovastatin—atherosclerosis	0.00149	0.0131	CcSEcCtD
Dolutegravir—Hepatitis—Rosuvastatin—atherosclerosis	0.00147	0.0129	CcSEcCtD
Dolutegravir—Abdominal discomfort—Simvastatin—atherosclerosis	0.00139	0.0122	CcSEcCtD
Dolutegravir—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.00134	0.0118	CcSEcCtD
Dolutegravir—Mental disorder—Rosuvastatin—atherosclerosis	0.00129	0.0113	CcSEcCtD
Dolutegravir—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.00128	0.0113	CcSEcCtD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—ESR2—atherosclerosis	0.00126	0.0451	CbGpPWpGaD
Dolutegravir—Flatulence—Rosuvastatin—atherosclerosis	0.00126	0.0111	CcSEcCtD
Dolutegravir—Hepatitis—Lovastatin—atherosclerosis	0.00124	0.0109	CcSEcCtD
Dolutegravir—Hepatitis—Ezetimibe—atherosclerosis	0.00122	0.0107	CcSEcCtD
Dolutegravir—Hepatitis—Simvastatin—atherosclerosis	0.00116	0.0102	CcSEcCtD
Dolutegravir—Immune system disorder—Ezetimibe—atherosclerosis	0.0011	0.00968	CcSEcCtD
Dolutegravir—Mental disorder—Ezetimibe—atherosclerosis	0.00107	0.00939	CcSEcCtD
Dolutegravir—Hepatitis—Niacin—atherosclerosis	0.00107	0.00938	CcSEcCtD
Dolutegravir—Flatulence—Lovastatin—atherosclerosis	0.00107	0.00937	CcSEcCtD
Dolutegravir—Hepatitis—Pravastatin—atherosclerosis	0.00105	0.00924	CcSEcCtD
Dolutegravir—Flatulence—Ezetimibe—atherosclerosis	0.00105	0.00919	CcSEcCtD
Dolutegravir—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00102	0.00898	CcSEcCtD
Dolutegravir—Mental disorder—Simvastatin—atherosclerosis	0.00102	0.00895	CcSEcCtD
Dolutegravir—Flatulence—Simvastatin—atherosclerosis	0.000998	0.00877	CcSEcCtD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—IL10—atherosclerosis	0.000975	0.0348	CbGpPWpGaD
Dolutegravir—Vertigo—Lovastatin—atherosclerosis	0.000973	0.00855	CcSEcCtD
Dolutegravir—Insomnia—Rosuvastatin—atherosclerosis	0.000943	0.00829	CcSEcCtD
Dolutegravir—POU2F2—BCR signaling pathway—NFKB1—atherosclerosis	0.000938	0.0335	CbGpPWpGaD
Dolutegravir—POU2F2—BCR signaling pathway—MAPK8—atherosclerosis	0.000922	0.0329	CbGpPWpGaD
Dolutegravir—Flatulence—Niacin—atherosclerosis	0.000916	0.00805	CcSEcCtD
Dolutegravir—Vertigo—Simvastatin—atherosclerosis	0.00091	0.00799	CcSEcCtD
Dolutegravir—Flatulence—Pravastatin—atherosclerosis	0.000902	0.00793	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000898	0.00789	CcSEcCtD
Dolutegravir—UGT1A1—Porphyrin metabolism—HMOX1—atherosclerosis	0.000891	0.0318	CbGpPWpGaD
Dolutegravir—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000852	0.00749	CcSEcCtD
Dolutegravir—Nervous system disorder—Ezetimibe—atherosclerosis	0.00085	0.00747	CcSEcCtD
Dolutegravir—Skin disorder—Ezetimibe—atherosclerosis	0.000842	0.0074	CcSEcCtD
Dolutegravir—Vertigo—Niacin—atherosclerosis	0.000835	0.00734	CcSEcCtD
Dolutegravir—Abdominal pain—Rosuvastatin—atherosclerosis	0.000824	0.00724	CcSEcCtD
Dolutegravir—Vertigo—Pravastatin—atherosclerosis	0.000822	0.00723	CcSEcCtD
Dolutegravir—POU2F2—BCR signaling pathway—MAPK3—atherosclerosis	0.000806	0.0287	CbGpPWpGaD
Dolutegravir—Insomnia—Lovastatin—atherosclerosis	0.000799	0.00702	CcSEcCtD
Dolutegravir—UGT1A1—Estrogen metabolism—GSTM1—atherosclerosis	0.000793	0.0283	CbGpPWpGaD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000786	0.00691	CcSEcCtD
Dolutegravir—Insomnia—Ezetimibe—atherosclerosis	0.000784	0.00689	CcSEcCtD
Dolutegravir—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000768	0.00675	CcSEcCtD
Dolutegravir—Fatigue—Lovastatin—atherosclerosis	0.000762	0.00669	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000748	0.00657	CcSEcCtD
Dolutegravir—Asthenia—Rosuvastatin—atherosclerosis	0.000748	0.00657	CcSEcCtD
Dolutegravir—Insomnia—Simvastatin—atherosclerosis	0.000747	0.00657	CcSEcCtD
Dolutegravir—Fatigue—Ezetimibe—atherosclerosis	0.000747	0.00656	CcSEcCtD
Dolutegravir—POU2F2—Ectoderm Differentiation—CCL2—atherosclerosis	0.000744	0.0265	CbGpPWpGaD
Dolutegravir—Pruritus—Rosuvastatin—atherosclerosis	0.000738	0.00648	CcSEcCtD
Dolutegravir—Skin disorder—Niacin—atherosclerosis	0.000737	0.00648	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000722	0.00635	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000713	0.00627	CcSEcCtD
Dolutegravir—Diarrhoea—Rosuvastatin—atherosclerosis	0.000713	0.00627	CcSEcCtD
Dolutegravir—Fatigue—Simvastatin—atherosclerosis	0.000712	0.00626	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000709	0.00623	CcSEcCtD
Dolutegravir—Abdominal pain—Lovastatin—atherosclerosis	0.000698	0.00614	CcSEcCtD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—AHR—atherosclerosis	0.000693	0.0247	CbGpPWpGaD
Dolutegravir—Dizziness—Rosuvastatin—atherosclerosis	0.000689	0.00606	CcSEcCtD
Dolutegravir—Insomnia—Niacin—atherosclerosis	0.000686	0.00603	CcSEcCtD
Dolutegravir—Abdominal pain—Ezetimibe—atherosclerosis	0.000685	0.00602	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000676	0.00594	CcSEcCtD
Dolutegravir—Insomnia—Pravastatin—atherosclerosis	0.000676	0.00594	CcSEcCtD
Dolutegravir—Rash—Rosuvastatin—atherosclerosis	0.000657	0.00578	CcSEcCtD
Dolutegravir—Dermatitis—Rosuvastatin—atherosclerosis	0.000657	0.00577	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Niacin—atherosclerosis	0.000655	0.00576	CcSEcCtD
Dolutegravir—Abdominal pain—Simvastatin—atherosclerosis	0.000653	0.00574	CcSEcCtD
Dolutegravir—Headache—Rosuvastatin—atherosclerosis	0.000653	0.00574	CcSEcCtD
Dolutegravir—Hypersensitivity—Lovastatin—atherosclerosis	0.000651	0.00572	CcSEcCtD
Dolutegravir—Fatigue—Pravastatin—atherosclerosis	0.000644	0.00566	CcSEcCtD
Dolutegravir—Hypersensitivity—Ezetimibe—atherosclerosis	0.000638	0.00561	CcSEcCtD
Dolutegravir—Asthenia—Lovastatin—atherosclerosis	0.000634	0.00557	CcSEcCtD
Dolutegravir—Pruritus—Lovastatin—atherosclerosis	0.000625	0.00549	CcSEcCtD
Dolutegravir—Asthenia—Ezetimibe—atherosclerosis	0.000622	0.00546	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Niacin—atherosclerosis	0.00062	0.00545	CcSEcCtD
Dolutegravir—Nausea—Rosuvastatin—atherosclerosis	0.000619	0.00544	CcSEcCtD
Dolutegravir—Pruritus—Ezetimibe—atherosclerosis	0.000613	0.00539	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000611	0.00537	CcSEcCtD
Dolutegravir—Hypersensitivity—Simvastatin—atherosclerosis	0.000609	0.00535	CcSEcCtD
Dolutegravir—Diarrhoea—Lovastatin—atherosclerosis	0.000604	0.00531	CcSEcCtD
Dolutegravir—Abdominal pain—Niacin—atherosclerosis	0.0006	0.00527	CcSEcCtD
Dolutegravir—Asthenia—Simvastatin—atherosclerosis	0.000593	0.00521	CcSEcCtD
Dolutegravir—Diarrhoea—Ezetimibe—atherosclerosis	0.000593	0.00521	CcSEcCtD
Dolutegravir—Abdominal pain—Pravastatin—atherosclerosis	0.000591	0.00519	CcSEcCtD
Dolutegravir—Pruritus—Simvastatin—atherosclerosis	0.000585	0.00514	CcSEcCtD
Dolutegravir—Dizziness—Lovastatin—atherosclerosis	0.000584	0.00513	CcSEcCtD
Dolutegravir—Dizziness—Ezetimibe—atherosclerosis	0.000573	0.00504	CcSEcCtD
Dolutegravir—Diarrhoea—Simvastatin—atherosclerosis	0.000565	0.00497	CcSEcCtD
Dolutegravir—Vomiting—Lovastatin—atherosclerosis	0.000562	0.00494	CcSEcCtD
Dolutegravir—Hypersensitivity—Niacin—atherosclerosis	0.000559	0.00491	CcSEcCtD
Dolutegravir—Rash—Lovastatin—atherosclerosis	0.000557	0.00489	CcSEcCtD
Dolutegravir—Dermatitis—Lovastatin—atherosclerosis	0.000556	0.00489	CcSEcCtD
Dolutegravir—Headache—Lovastatin—atherosclerosis	0.000553	0.00486	CcSEcCtD
Dolutegravir—Vomiting—Ezetimibe—atherosclerosis	0.000551	0.00484	CcSEcCtD
Dolutegravir—Hypersensitivity—Pravastatin—atherosclerosis	0.00055	0.00484	CcSEcCtD
Dolutegravir—Dizziness—Simvastatin—atherosclerosis	0.000546	0.0048	CcSEcCtD
Dolutegravir—Rash—Ezetimibe—atherosclerosis	0.000546	0.0048	CcSEcCtD
Dolutegravir—Dermatitis—Ezetimibe—atherosclerosis	0.000546	0.0048	CcSEcCtD
Dolutegravir—Asthenia—Niacin—atherosclerosis	0.000544	0.00478	CcSEcCtD
Dolutegravir—POU2F2—BCR signaling pathway—AKT1—atherosclerosis	0.000543	0.0194	CbGpPWpGaD
Dolutegravir—Headache—Ezetimibe—atherosclerosis	0.000543	0.00477	CcSEcCtD
Dolutegravir—Pruritus—Niacin—atherosclerosis	0.000537	0.00472	CcSEcCtD
Dolutegravir—Asthenia—Pravastatin—atherosclerosis	0.000536	0.00471	CcSEcCtD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—CXCL8—atherosclerosis	0.000533	0.019	CbGpPWpGaD
Dolutegravir—Pruritus—Pravastatin—atherosclerosis	0.000529	0.00464	CcSEcCtD
Dolutegravir—Vomiting—Simvastatin—atherosclerosis	0.000525	0.00462	CcSEcCtD
Dolutegravir—Nausea—Lovastatin—atherosclerosis	0.000525	0.00461	CcSEcCtD
Dolutegravir—Rash—Simvastatin—atherosclerosis	0.000521	0.00458	CcSEcCtD
Dolutegravir—Dermatitis—Simvastatin—atherosclerosis	0.000521	0.00457	CcSEcCtD
Dolutegravir—Diarrhoea—Niacin—atherosclerosis	0.000519	0.00456	CcSEcCtD
Dolutegravir—Headache—Simvastatin—atherosclerosis	0.000518	0.00455	CcSEcCtD
Dolutegravir—Nausea—Ezetimibe—atherosclerosis	0.000515	0.00452	CcSEcCtD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—IL1B—atherosclerosis	0.000512	0.0182	CbGpPWpGaD
Dolutegravir—Diarrhoea—Pravastatin—atherosclerosis	0.000511	0.00449	CcSEcCtD
Dolutegravir—Dizziness—Niacin—atherosclerosis	0.000502	0.00441	CcSEcCtD
Dolutegravir—Dizziness—Pravastatin—atherosclerosis	0.000494	0.00434	CcSEcCtD
Dolutegravir—Nausea—Simvastatin—atherosclerosis	0.000491	0.00431	CcSEcCtD
Dolutegravir—Vomiting—Niacin—atherosclerosis	0.000482	0.00424	CcSEcCtD
Dolutegravir—Rash—Niacin—atherosclerosis	0.000478	0.0042	CcSEcCtD
Dolutegravir—Dermatitis—Niacin—atherosclerosis	0.000478	0.0042	CcSEcCtD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—NFKB1—atherosclerosis	0.000477	0.017	CbGpPWpGaD
Dolutegravir—Headache—Niacin—atherosclerosis	0.000475	0.00418	CcSEcCtD
Dolutegravir—Vomiting—Pravastatin—atherosclerosis	0.000475	0.00417	CcSEcCtD
Dolutegravir—Rash—Pravastatin—atherosclerosis	0.000471	0.00414	CcSEcCtD
Dolutegravir—Dermatitis—Pravastatin—atherosclerosis	0.000471	0.00414	CcSEcCtD
Dolutegravir—Headache—Pravastatin—atherosclerosis	0.000468	0.00411	CcSEcCtD
Dolutegravir—Nausea—Niacin—atherosclerosis	0.000451	0.00396	CcSEcCtD
Dolutegravir—Nausea—Pravastatin—atherosclerosis	0.000444	0.0039	CcSEcCtD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	0.000433	0.0154	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—TNF—atherosclerosis	0.000371	0.0132	CbGpPWpGaD
Dolutegravir—UGT1A1—Biological oxidations—CYP7A1—atherosclerosis	0.000316	0.0113	CbGpPWpGaD
Dolutegravir—UGT1A1—Metapathway biotransformation—CYP7A1—atherosclerosis	0.000311	0.0111	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—IL6—atherosclerosis	0.0003	0.0107	CbGpPWpGaD
Dolutegravir—UGT1A1—Biological oxidations—CYP27A1—atherosclerosis	0.000292	0.0104	CbGpPWpGaD
Dolutegravir—UGT1A1—Metapathway biotransformation—CYP27A1—atherosclerosis	0.000288	0.0103	CbGpPWpGaD
Dolutegravir—UGT1A1—Phase II conjugation—GSTM1—atherosclerosis	0.000223	0.00795	CbGpPWpGaD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—atherosclerosis	0.00022	0.00785	CbGpPWpGaD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—atherosclerosis	0.000196	0.007	CbGpPWpGaD
Dolutegravir—UGT1A1—NRF2 pathway—HMOX1—atherosclerosis	0.000159	0.00569	CbGpPWpGaD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—atherosclerosis	0.000153	0.00544	CbGpPWpGaD
Dolutegravir—UGT1A1—NRF2 pathway—GSTM1—atherosclerosis	0.000149	0.0053	CbGpPWpGaD
Dolutegravir—UGT1A1—NRF2 pathway—AGER—atherosclerosis	0.000143	0.00511	CbGpPWpGaD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—atherosclerosis	0.000142	0.00508	CbGpPWpGaD
Dolutegravir—UGT1A1—Biological oxidations—GSTM1—atherosclerosis	0.00013	0.00465	CbGpPWpGaD
Dolutegravir—UGT1A1—Metapathway biotransformation—GSTM1—atherosclerosis	0.000129	0.00458	CbGpPWpGaD
Dolutegravir—UGT1A1—NRF2 pathway—PDGFB—atherosclerosis	0.000128	0.00456	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—LDLRAP1—atherosclerosis	9.24e-05	0.0033	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PLTP—atherosclerosis	8.69e-05	0.0031	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—LTA4H—atherosclerosis	7.53e-05	0.00269	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ABCG8—atherosclerosis	7.53e-05	0.00269	CbGpPWpGaD
Dolutegravir—UGT1A1—NRF2 pathway—TGFB1—atherosclerosis	6.06e-05	0.00216	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ABCG1—atherosclerosis	5.96e-05	0.00212	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—FABP4—atherosclerosis	5.6e-05	0.002	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—LCAT—atherosclerosis	5.6e-05	0.002	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—APOA4—atherosclerosis	5.5e-05	0.00196	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CYP7A1—atherosclerosis	5.4e-05	0.00193	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CYP27A1—atherosclerosis	4.99e-05	0.00178	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ALOX15—atherosclerosis	4.73e-05	0.00169	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ALOX5AP—atherosclerosis	4.73e-05	0.00169	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PLA2G2A—atherosclerosis	4.73e-05	0.00169	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—APOA2—atherosclerosis	4.73e-05	0.00169	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ABCG5—atherosclerosis	4.67e-05	0.00167	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—LPA—atherosclerosis	4.51e-05	0.00161	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—BGN—atherosclerosis	4.37e-05	0.00156	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—APOA5—atherosclerosis	4.33e-05	0.00154	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PLA2G1B—atherosclerosis	4.17e-05	0.00149	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ALOX5—atherosclerosis	4.02e-05	0.00143	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—NAMPT—atherosclerosis	3.61e-05	0.00129	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—LIPC—atherosclerosis	3.59e-05	0.00128	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—APOC3—atherosclerosis	3.56e-05	0.00127	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—LDLR—atherosclerosis	3.54e-05	0.00126	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CETP—atherosclerosis	3.46e-05	0.00123	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—SCARB1—atherosclerosis	3.31e-05	0.00118	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—HMGCR—atherosclerosis	3.13e-05	0.00112	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ABCA1—atherosclerosis	2.79e-05	0.000994	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—HMOX1—atherosclerosis	2.39e-05	0.000853	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—APOB—atherosclerosis	2.29e-05	0.000817	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—GSTM1—atherosclerosis	2.23e-05	0.000795	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—LPL—atherosclerosis	2.19e-05	0.00078	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—GPX1—atherosclerosis	2.13e-05	0.000761	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CD36—atherosclerosis	2.08e-05	0.000741	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—MTHFR—atherosclerosis	1.97e-05	0.000703	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PPARA—atherosclerosis	1.93e-05	0.000689	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—AGT—atherosclerosis	1.87e-05	0.000668	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—APOE—atherosclerosis	1.83e-05	0.000654	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CAV1—atherosclerosis	1.82e-05	0.000648	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—APOA1—atherosclerosis	1.81e-05	0.000647	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PIK3CG—atherosclerosis	1.66e-05	0.00059	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PPARG—atherosclerosis	1.6e-05	0.00057	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—INS—atherosclerosis	1.57e-05	0.000559	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ALB—atherosclerosis	1.44e-05	0.000512	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—NOS3—atherosclerosis	1.37e-05	0.00049	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PTGS2—atherosclerosis	1.26e-05	0.000448	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—AKT1—atherosclerosis	6.32e-06	0.000225	CbGpPWpGaD
